CDK4 and breast cancer: Additionally, a dysregulation of cell cycle components is a common feature in ER+ BC, especially the Cyclin D-Cyclin Dependent Kinase (CDK)4/6-Retinoblastoma (Rb) axis in the luminal B subtype [29,30].